Patents by Inventor Eun-Ji Joung

Eun-Ji Joung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for prevention or treatment of arthritis, containing extract as active ingredient
    Patent number: 10286021
    Abstract: The present invention relates to a composition for the prevention or treatment of arthritis, the composition containing a Sargassum serratifolium extract as an active ingredient. The extract of Sargassum serratifolium according to the present invention has an excellent activity to reduce or inhibit the activity of IL-1?, IL-6, or TNF-?, which is an inflammatory cytokine, and has an excellent effect alleviating arthritis in an arthritis animal model so that it can be usefully used as a composition for treating arthritis. In addition, there is no cytotoxicity, and toxicity to the drug and side effects are avoided so that it can be safely used even for long-term use, and it is stable in the body.
    Type: Grant
    Filed: February 11, 2016
    Date of Patent: May 14, 2019
    Assignee: Pukyong National University Industry-University Cooperation Foundation
    Inventors: Hyeung-Rak Kim, Mi-Sung Kwon, Eun-Ji Joung
  • COMPOSITION FOR PREVENTION OR TREATMENT OF ARTHRITIS, CONTAINING SARGASSUM SERRATIFOLIUM EXTRACT AS ACTIVE INGREDIENT
    Publication number: 20180221424
    Abstract: The present invention relates to a composition for the prevention or treatment of arthritis, the composition containing a Sargassum serratifolium extract as an active ingredient. The extract of Sargassum serratifolium according to the present invention has an excellent activity to reduce or inhibit the activity of IL-1?, IL-6, or TNF-?, which is an inflammatory cytokine, and has an excellent effect alleviating arthritis in an arthritis animal model so that it can be usefully used as a composition for treating arthritis. In addition, there is no cytotoxicity, and toxicity to the drug and side effects are avoided so that it can be safely used even for long-term use, and it is stable in the body.
    Type: Application
    Filed: February 11, 2016
    Publication date: August 9, 2018
    Applicant: PUKYONG NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
    Inventors: Hyeung-Rak Kim, Mi-Sung Kwon, Eun-Ji Joung